MedTrace Logo

Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD

NCT01459770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-04-06

No results posted yet for this study

Summary

Transitional care strategies focused on enhancing the accuracy and comprehensiveness of medication information transfer will lead to improved health outcomes among hospitalized patients with chronic kidney disease.

Conditions

Interventions

OTHER

Medication Information Transfer Intervention

A pharmacist will visit participants randomized to the intervention group in their homes within 5 days of hospital discharge to administer the 5As Medication Self-Management intervention: Assessment, Advise, Agreement, Assistance, Arrangements.

OTHER

Usual care for hospital discharge

Patients will receive medication information according to standard practice for discharge of hospitalized patients.

Sponsors & Collaborators

  • Washington State University

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Health Sciences & Services Authority of Spokane County

    collaborator UNKNOWN

  • Providence Sacred Heart Medical Center & Children's Hospital

    collaborator OTHER

  • Providence Medical Research Center

    lead OTHER

Principal Investigators

  • Katherine R Tuttle, MD · Providence Sacred Heart Medical Center and Children's Hospital; University of Washington School of Medicine

  • Cynthia L Corbett, PhD · Washington State University College of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01459770 on ClinicalTrials.gov